Elizabeth G Livingston
Affiliation: Duke University Medical Center
- Management of HIV in pregnancyElizabeth G Livingston
Duke University Medical Center, Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Trent Drive, Durham, NC 27710, USA
Curr Womens Health Rep 2:245-52. 2002..Simple, safe, and effective methods of preventing mother-to-child transmission are needed for the developing world...
- Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapyElizabeth G Livingston
Duke University, Durham, NC 27710, USA
Obstet Gynecol 110:391-7. 2007..To evaluate the effect of protease inhibitors on lipid and lactate levels and gastrointestinal symptoms in pregnancy...
- Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected womenElizabeth G Livingston
Duke University, Durham, North Carolina 27710, USA
Obstet Gynecol 116:335-43. 2010..To estimate risk of infant respiratory morbidity associated with cesarean delivery before labor and ruptured membranes among HIV-1-infected women...
- Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancyCarla E Ransom
Department of Obstetrics and Gynecology, Vanderbilt University, Nashville, TN Center for Biostatistics in AIDS Research and Department of Epidemiology, Harvard School of Public Health, Boston, MA Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, MD and Department of Obstetrics and Gynecology, Duke University Medical School, Durham, NC
J Acquir Immune Defic Syndr 64:374-81. 2013..To determine whether maternal use of tenofovir disoproxil fumarate for treatment of HIV in pregnancy predicts fetal and infant growth...